Document:

EXHIBIT 10.40
$300,000.00                                                        May 12, 2000

                                 PROMISSORY NOTE

      FOR VALUE RECEIVED, the undersigned, PAUL LUNDBERG (the "Maker"), hereby
promises to pay to the order of ZAMBA CORPORATION, a Delaware corporation, or
registered assigns (the "Holder"), the principal sum of Two Hundred THOUSAND
DOLLARS (the "Note Amount) in ONE (1) payment of principal and interest in the
amount of $356,430 on the earlier of the Makers separation of employment with
the Holder, or May 12, 2002. Interest shall be calculated at the rate equal to
the Prime Rate compounded annually, which for purposes of this Note, shall mean
the rate published by the Wall Street Journal as of the date of this Note, which
is 9.00%

      The payment made hereunder shall be made in lawful currency of the United
States of America in cash or by check payable to the Holder, Attn: Controller,
7301 Ohms Lane, Suite 200, Minneapolis, Minnesota 55439, or at such other place
as the registered holder may designate in writing. The Maker reserves the right
to prepay all or any portion of this Note at any time and from time to time
without premium or penalty of any kind, provided that interest shall continue to
accrue on the original Note Amount unless accrued interest is added to the
amount prepaid. Prepayment shall not change the Payment Amount, but may change
the number of payments required.

      No delay or failure by the registered Holder in exercising any right,
power, privilege or remedy hereunder shall affect such right, power, privilege
or remedy or be deemed to be a waiver of the same or any part thereof, nor shall
any single or partial exercise thereof or any failure to exercise the same in
any instance preclude any further or future exercise thereof, or exercise of any
other right, power, privilege or remedy, and the rights and privileges provided
for hereunder are cumulative and not exclusive. The delay or failure to exercise
any right hereunder shall not waive such right.

      By executing this Note the Maker represents to the registered Holder that
he is duly authorized and empowered to execute and deliver this Note and that
this Note constitutes the legal and binding obligation of the Maker, enforceable
against the Maker in accordance with its terms.

      THIS PROMISSORY NOTE SHALL BE GOVERNED BY AND CONTRUED AND ENFORCED IN
ACCORDANCE WITH THE LAWS OF THE STATE OF MINNESOTA.

      IN WITNESS WHEREOF, the undersigned has duly caused this Note to be
executed and delivered at the place specified above and as of the date first
written above.

                                          By /s Paul Lundberg
                                                Paul LundbergExhibit 10.41

March 6, 2001

Mr. Richard De Francisco
*
Dear Richard:

On behalf of Zamba, I am both extremely pleased and excited to offer you an
opportunity to join us as Executive Vice President of Sales, reporting to the
President and CEO. You would be based in our Southern California office.

We would like to offer you an exempt, full time position, which includes:

-  Starting semi-monthly salary of $10,416.67 ($250,000 annualized).

-  Subject to final Board approval of your grant, you will be granted an option
   to purchase 450,000 shares of the company's common stock at a predetermined
   price. In accordance with the terms of our stock option plans, 25% of the
   initial grant will become vested at your one-year anniversary date and 6.25%
   quarterly thereafter, and will be fully vested at the end of four years.

-  An incentive compensation plan paying .2% of the company's total monthly
   revenue, paid monthly at the same timing in which salespersons are paid. You
   will also receive additional cash bonuses of $50,000 upon our recognition of
   $60,000,000 in revenue during 2001, and additonal $50,000 bonuses upon each
   additonal $10,000,000 in recognized revenue during 2001. Revenue from
   acquired companies will not count towards the revenue calculations for these
   incentive bonuses.

-  If you are terminated by Zamba during the first year of your employment,
   other than as part of a change of control, in which case your change of
   control agreement would take precedence, or for cause, your salary will
   continue and your stock options will continue vesting for the remainder of
   the year.

-  I will ask the Board of Directors to approve a change of control agreement
   that is consistent with other executives in the company.

This offer is contingent upon your executing the attached employment agreement
before commencing your employment, the successful completion of your reference
and background investigation, and compliance with the Immigration Reform Control
Act of 1986 (IRCA). Also, if you are not a U.S. citizen, U.S. permanent
resident, nor been granted asylee or refugee status, this offer is contingent
upon your ability to meet Zamba's Immigration policy guidelines and INS approval
of your right to reside and work in the United States (i.e., approval of
appropriate work visa or status for Zamba, Minneapolis). Should you qualify,
Zamba will pay the reasonable and usual costs to obtain the appropriate
nonimmigrant classification.

This offer will remain valid for seven days from the date of this letter unless
we notify you otherwise. You should understand that this offer, including the
salary, options, incentive plan, salary continuation, and change of control
agreement, does not constitute a contract of employment for any specified period
of time but will create an "employment at will" relationship.
<PAGE>

Please sign this letter, indicating acceptance of this offer and your
anticipated start date. Return the signed copy in the enclosed envelope and keep
a copy for your records. Please review and complete the enclosed forms. Bring
these forms and the appropriate I-9 documentation with you on your first day of
work. At orientation we will cover your benefits, review your forms and answer
any questions you may have.

Richard, we believe that you will find Zamba a truly exciting and fulfilling
place to work. We look forward to your joining us and contributing to our
success.

Sincerely,

Doug Holden
President and CEO

I accept this offer:

/s/ Richard J. De Francisco       3/6/2001
NAME                              Date

Anticipated Start Date: March 12, 2001

ENCL:

-  Benefits Summary
-  Proprietary Information and Invention Agreement/Confidential Disclosure
   Agreement/Terms of Employment
-  I-9 and W-4 Forms
-  Export Control Document
-  MN child Support (MN residents only)
-  Background Release Form<PAGE>

================================================================================

                        BEI MEDICAL SYSTEMS COMPANY, INC.

                          REGISTRATION RIGHTS AGREEMENT

================================================================================
<PAGE>

                                TABLE OF CONTENTS

                                                                            PAGE

SECTION 1. GENERAL...........................................................1

      1.1   Definitions......................................................1

SECTION 2. REGISTRATION; RESTRICTIONS ON TRANSFER............................2

      2.1   Restrictions on Transfer.........................................2

      2.2   Registration.....................................................4

      2.3   Piggyback Registrations..........................................4

      2.4   Eligibility for Form S-3.........................................5

      2.5   Expenses of Registration.........................................6

      2.6   Obligations of the Company.......................................6

      2.7   Holder's Obligations.............................................7

      2.8   Other Transactions...............................................8

      2.9   Indemnification..................................................8

      2.10  Furnishing Information..........................................10

      2.11  Assignment of Registration Rights...............................11

      2.12  Amendment of Registration Rights................................11

      2.13  Rule 144 Reporting..............................................11

SECTION 3. COVENANTS OF THE COMPANY.........................................11

      3.1   Basic Financial Information and Reporting.......................11

      3.2   Confidentiality of Records......................................12

      3.3   Reservation of Common Stock.....................................12

      3.4   Observer Rights.................................................12

      3.5   Directors' Expenses.............................................12

      3.6   Directors' Liability and Indemnification........................12

      3.7   Termination of Covenants........................................13

SECTION 4. MISCELLANEOUS....................................................13

      4.1   Governing Law...................................................13

      4.2   Survival........................................................13

      4.3   Holder Information..............................................14

      4.4   Successors and Assigns..........................................14

                                       i
<PAGE>

                                TABLE OF CONTENTS
                                   (CONTINUED)

                                                                            PAGE

      4.5   Entire Agreement................................................14

      4.6   Severability....................................................14

      4.7   Amendment and Waiver............................................14

      4.8   Delays or Omissions.............................................15

      4.9   Notices.........................................................15

      4.10  Attorneys' Fees.................................................15

      4.11  Titles and Subtitles............................................15

      4.12  Additional Investors............................................15

      4.13  Counterparts....................................................15

                                       ii

<PAGE>

                        BEI MEDICAL SYSTEMS COMPANY, INC.

                          REGISTRATION RIGHTS AGREEMENT

      THIS REGISTRATION RIGHTS AGREEMENT (the "Agreement") is entered into as of
the 14th day of February, 2001, by and among BEI MEDICAL SYSTEMS COMPANY, INC.,
a Delaware corporation (the "Company") and the investors listed on Exhibit A
hereto, referred to hereinafter as the "Investors" and each individually as an
"Investor."

                                    RECITALS

      WHEREAS, the Investors are purchasing shares of the Company's Series A
Convertible Preferred Stock (the "Series A Stock") pursuant to that certain
Series A Convertible Preferred Stock Purchase Agreement (the "Purchase
Agreement") of even date herewith (the "Financing");

      WHEREAS, the obligations in the Purchase Agreement are conditioned upon
the execution and delivery of this Agreement; and

      WHEREAS, in connection with the consummation of the Financing, the parties
desire to enter into this Agreement in order to grant registration, information
and other rights to the Investors as set forth below.

      NOW, THEREFORE, in consideration of the premises and for other good and
valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties agree hereto as follows:

SECTION 1. GENERAL.

      1.1 Definitions. As used in this Agreement the following terms shall have
the following respective meanings:

            "Exchange Act" means the Securities Exchange Act of 1934, as
amended.

            "Form S-3" means such form under the Securities Act as in effect on
the date hereof or any successor or similar registration form under the
Securities Act subsequently adopted by the SEC which permits inclusion or
incorporation of substantial information by reference to other documents filed
by the Company with the SEC.

            "Holder" means any person owning of record Registrable Securities
that have not been sold to the public or any assignee of record of such
Registrable Securities in accordance with Section 2.11 hereof.

                                       1
<PAGE>

            "Register," "registered," and "registration" refer to a registration
effected by preparing and filing a registration statement in compliance with the
Securities Act, and the declaration or ordering of effectiveness of such
registration statement or document.

            "Registrable Securities" means (a) Common Stock of the Company
issued or issuable upon conversion of the Shares; and (b) any Common Stock of
the Company issued as (or issuable upon the conversion or exercise of any
warrant, right or other security which is issued as) a dividend or other
distribution with respect to, or in exchange for or in replacement of the Common
Stock issuable upon conversion of the Shares. Notwithstanding the foregoing,
Registrable Securities shall not include any securities sold by a person to the
public either pursuant to a registration statement or Rule 144 or sold in a
private transaction in which the transferor's rights under Section 2 of this
Agreement are not assigned.

            "Registrable Securities then outstanding" shall be the number of
shares determined by calculating the total number of shares of the Company's
Common Stock that are Registrable Securities and either (a) are then issued and
outstanding or (b) are issuable pursuant to then exercisable or convertible
securities.

            "Registration Expenses" shall mean, except as otherwise provided
herein, all expenses incurred by the Company in complying with Sections 2.2 and
2.3 hereof, including, without limitation, all registration and filing fees,
printing expenses, fees and disbursements of counsel for the Company, reasonable
fees and disbursements of a single special counsel for the Holders, blue sky
fees and expenses and the expense of any special audits incident to or required
by any such registration (but excluding the compensation of regular employees of
the Company which shall be paid in any event by the Company).

            "SEC" or "Commission" means the Securities and Exchange Commission.

            "Securities Act" shall mean the Securities Act of 1933, as amended.

            "Selling Expenses" shall mean all underwriting discounts and selling
commissions applicable to the sale.

            "Shares" shall mean the Company's Series A Stock issued pursuant to
the Purchase Agreement and held by the Investors listed on Exhibit A hereto and
their permitted assigns.

            "Special Registration Statement" shall mean a registration statement
relating to any employee benefit plan or with respect to any corporate
reorganization or other transaction under Rule 145 of the Securities Act.

SECTION 2. REGISTRATION; RESTRICTIONS ON TRANSFER.

      2.1 Restrictions on Transfer.

                                       2
<PAGE>

            (a) Each Holder agrees not to make any disposition of all or any
portion of the Shares or Registrable Securities unless and until:

                  (i) There is then in effect a registration statement under the
Securities Act covering such proposed disposition and such disposition is made
in accordance with such registration statement; or

                  (ii) (A) The transferee has agreed in writing to be bound by
the terms of this Agreement, (B) such Holder shall have notified the Company of
the proposed disposition and shall have furnished the Company with a detailed
statement of the circumstances surrounding the proposed disposition, and (C) if
reasonably requested by the Company, such Holder shall have furnished the
Company with an opinion of counsel, reasonably satisfactory to the Company, that
such disposition will not require registration of such shares under the
Securities Act. It is agreed that the Company will not require opinions of
counsel for transactions made pursuant to Rule 144 except in unusual
circumstances; or

                  (iii) Notwithstanding the provisions of paragraphs (i) and
(ii) above, no such registration statement or opinion of counsel shall be
necessary for a transfer by a Holder which is (A) a partnership to its partners
or former partners in accordance with partnership interests, (B) a corporation
to its stockholders in accordance with their interest in the corporation, (C) a
limited liability company to its members or former members in accordance with
their interest in the limited liability company, or (D) to the Holder's family
member or trust for the benefit of an individual Holder; provided that in each
case the Holder shall have notified the Company of the proposed transfer or
disposition at least 10 days prior to such transfer and the transferee will be
subject to the terms of this Agreement to the same extent as if he were an
original Holder hereunder.

            (b) Each certificate representing Shares or Registrable Securities
shall (unless otherwise permitted by the provisions of the Agreement) be stamped
or otherwise imprinted with a legend substantially similar to the following (in
addition to any legend required under applicable state securities laws):

      THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE
      SECURITIES ACT OF 1933 (THE "ACT") AND MAY NOT BE OFFERED, SOLD OR
      OTHERWISE TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL
      REGISTERED UNDER THE ACT OR UNLESS THE COMPANY HAS RECEIVED AN OPINION OF
      COUNSEL SATISFACTORY TO THE COMPANY AND ITS COUNSEL THAT SUCH REGISTRATION
      IS NOT REQUIRED.

      THE TRANSFER OF SHARES REPRESENTED BY THIS CERTIFICATE IS SUBJECT TO
      CERTAIN RESTRICTIONS SPECIFIED IN THE REGISTRATION RIGHTS AGREEMENT DATED
      FEBRUARY 14, 2001, BETWEEN THE COMPANY AND CERTAIN INVESTORS, AND NO

                                       3
<PAGE>

      TRANSFER OF SHARES SHALL BE VALID OR EFFECTIVE ABSENT COMPLIANCE WITH SUCH
      RESTRICTIONS.

            (c) The Company shall be obligated to reissue promptly unlegended
certificates at the request of any holder thereof if the holder shall have
obtained an opinion of counsel (which counsel may be counsel to the Company)
reasonably acceptable to the Company to the effect that the securities proposed
to be disposed of may lawfully be so disposed of without registration,
qualification or legend.

            (d) Any legend endorsed on an instrument pursuant to applicable
state securities laws and the stop-transfer instructions with respect to such
securities shall be removed upon receipt by the Company of an order of the
appropriate blue sky authority authorizing such removal.

      2.2 Registration.

            (a) The Company shall prepare and file as soon as practicable, but
in no event later than March 16, 2001 (the "Filing Deadline"), with the SEC a
registration statement on Form S-3 covering the resale of all of the Registrable
Securities (the "Registration Statement") issuable upon full conversion of the
Series A Stock. The Company shall use its best efforts to cause the Registration
Statement filed hereunder to become effective as soon as practicable, but in no
event later than April 16, 2001 (or June 14, 2001 if reviewed in writing by the
SEC).

            (b) The Holders shall furnish such information the Company may
reasonably request in connection with the preparation of the Registration
Statement. Upon registration of the resale of the Registrable Securities with
the SEC pursuant to the terms of this Agreement, the Registrable Securities may
be sold in accordance with the Registration Statement under the Securities Act.

      2.3 Piggyback Registrations. The Company shall notify all Holders of
Registrable Securities in writing at least 10 days prior to the filing of any
registration statement under the Securities Act for purposes of a public
offering of securities of the Company (including, but not limited to,
registration statements relating to secondary offerings of securities of the
Company, but excluding Special Registration Statements) and will afford each
such Holder an opportunity to include in such registration statement all or part
of such Registrable Securities held by such Holder. Each Holder desiring to
include in any such registration statement all or any part of the Registrable
Securities held by it shall, within 10 days after the above-described notice
from the Company, so notify the Company in writing. Such notice shall state the
intended method of disposition of the Registrable Securities by such Holder. If
a Holder decides not to include all of its Registrable Securities in any
registration statement thereafter filed by the Company, such Holder shall
nevertheless continue to have the right to include any Registrable Securities in
any subsequent registration statement or registration statements as may be filed
by the Company with respect to offerings of its securities, all upon the terms
and conditions set forth herein.

                                       4
<PAGE>

            (a) Underwriting. If the registration statement under which the
Company gives notice under this Section 2.3 is for an underwritten offering, the
Company shall so advise the Holders of Registrable Securities. In such event,
the right of any such Holder to be included in a registration pursuant to this
Section 2.3 shall be conditioned upon such Holder's participation in such
underwriting and the inclusion of such Holder's Registrable Securities in the
underwriting to the extent provided herein. All Holders proposing to distribute
their Registrable Securities through such underwriting shall enter into an
underwriting agreement in customary form with the underwriter or underwriters
selected for such underwriting by the Company. Notwithstanding any other
provision of the Agreement, if the underwriter determines in good faith that
marketing factors require a limitation of the number of shares to be
underwritten, the number of shares that may be included in the underwriting
shall be allocated, first, to the Company; second, to the Holders on a pro rata
basis based on the total number of Registrable Securities held by the Holders;
and third, to any stockholder of the Company (other than a Holder) on a pro rata
basis. No such reduction shall reduce the securities being offered by the
Company for its own account to be included in the registration and underwriting.
In no event will shares of any other selling stockholder be included in such
registration which would reduce the number of shares which may be included by
Holders without the written consent of Holders of not less than 66 2/3% of the
Registrable Securities proposed to be sold in the offering. If any Holder
disapproves of the terms of any such underwriting, such Holder may elect to
withdraw therefrom by written notice to the Company and the underwriter,
delivered at least 10 business days prior to the effective date of the
registration statement. Any Registrable Securities excluded or withdrawn from
such underwriting shall be excluded and withdrawn from the registration. For any
Holder which is a partnership or corporation, the partners, retired partners and
stockholders of such Holder, or the estates and family members of any such
partners and retired partners and any trusts for the benefit of any of the
foregoing person shall be deemed to be a single "Holder," and any pro rata
reduction with respect to such "Holder" shall be based upon the aggregate amount
of shares carrying registration rights owned by all entities and individuals
included in such "Holder," as defined in this sentence.

            (b) Right to Terminate Registration. The Company shall have the
right to terminate or withdraw any registration initiated by it under this
Section 2.3 prior to the effectiveness of such registration whether or not any
Holder has elected to include securities in such registration. The Registration
Expenses of such withdrawn registration shall be borne by the Company in
accordance with Section 2.5 hereof.

            (c) Expiration of Piggyback Registration Rights. The registration
rights described under this Section 2.3 shall expire three years from the date
hereof.

      2.4 Eligibility for Form S-3. The Company represents and warrants that it
is currently eligible to register the resale of all of the Registrable
Securities issuable upon full conversion of the Series A Stock by the Holders on
a registration statement on Forms S-3 under the Securities Act for the account
of Holders (and not for or on behalf of Company). The Company shall file all
reports required to be filed by the Company under the Securities Act and the
Exchange Act with the SEC in a timely manner and take all other actions which
may be required so as to maintain such eligibility for the use of Forms S-3.

                                       5
<PAGE>

      2.5 Expenses of Registration. Except as specifically provided herein, all
Registration Expenses incurred in connection with any registration,
qualification or compliance pursuant to Section 2.2 or any registration under
Section 2.3 herein shall be borne by the Company, including reasonable legal
fees and cost of one special counsel of the selling stockholders not to exceed
$25,000. All Selling Expenses incurred in connection with any registrations
hereunder, shall be borne by the holders of the securities so registered pro
rata on the basis of the number of shares so registered. The Company shall not,
however, be required to pay for expenses of any registration proceeding begun
pursuant to Section 2.2, the request of which has been subsequently withdrawn by
the Holders unless the withdrawal is based upon material adverse information
concerning the Company of which the Holders were not aware at the time of such
request. If the Holders are required to pay the Registration Expenses, such
expenses shall be borne by the Holders of securities in proportion to the number
of shares being registered.

      2.6 Obligations of the Company. Whenever required to effect the
registration of any Registrable Securities, the Company shall, as expeditiously
as reasonably possible:

            (a) Prepare promptly and file with the SEC the registration
statement required by Section 2.2, and cause such registration statement
relating to Registrable Securities to become effective as soon as practicable
after such filing, and keep the registration statement effective pursuant to
Rule 415 and immediately available for use at all times until such date as is
the earlier of (i) the date on which all of the Registrable Securities have been
sold (and no further Registrable Securities may be issued in the future) and
(ii) the date on which all of the Registrable Securities (in the reasonable
opinion of counsel to the Holders) may be immediately sold to the public without
registration and without restriction as to the number of Registrable Securities
to be sold pursuant to Rule 144 (k) or any successor provision. The registration
statement (including any amendments or supplements thereto and prospectuses
contained therein and all documents incorporated by reference therein) shall not
contain any untrue statement of a material fact or omit to state a material fact
required to be stated therein, or necessary to make the statements therein not
misleading.

            (b) Prepare and file with the SEC such amendments and supplements to
such registration statement and the prospectus used in connection with such
registration statement as may be necessary to comply with the provisions of the
Securities Act with respect to the sale or disposition of all securities covered
by such registration statement for the period set forth in paragraph (a) above.

            (c) Furnish to the Holders such number of copies of a prospectus and
any amendments and supplements thereto in conformity with the requirements of
the Securities Act, and such other documents as they may reasonably request in
order to facilitate the disposition of Registrable Securities owned by them.

            (d) Use its reasonable efforts to register and qualify the
securities covered by such registration statement under such other securities or
Blue Sky laws of such jurisdictions as shall be reasonably requested by the
Holders; provided that the Company shall not be required in

                                       6
<PAGE>

connection therewith or as a condition thereto to qualify to do business or to
file a general consent to service of process in any such states or
jurisdictions.

            (e) In the event of any underwritten public offering, enter into and
perform its obligations under an underwriting agreement, in usual and customary
form, with the managing underwriter(s) of such offering. Each Holder
participating in such underwriting shall also enter into and perform its
obligations under such an agreement.

            (f) Notify each Holder of Registrable Securities covered by such
registration statement at any time when a prospectus relating thereto is
required to be delivered under the Securities Act of the happening of any event
as a result of which the prospectus included in such registration statement, as
then in effect, includes an untrue statement of a material fact or omits to
state a material fact required to be stated therein or necessary to make the
statements therein not misleading in the light of the circumstances then
existing. The Company will use reasonable efforts to amend or supplement such
prospectus in order to cause such prospectus not to include any untrue statement
of a material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein not misleading in the light
of the circumstances then existing.

            (g) Use its reasonable efforts to furnish, on the date that such
Registrable Securities are delivered to the underwriters for sale, if such
securities are being sold through underwriters, (i) an opinion, dated as of such
date, of the counsel representing the Company for the purposes of such
registration, in form and substance as is customarily given to underwriters in
an underwritten public offering, addressed to the underwriters, if any, and (ii)
a letter dated as of such date, from the independent certified public
accountants of the Company, in form and substance as is customarily given by
independent certified public accountants to underwriters in an underwritten
public offering addressed to the underwriters.

      2.7 Holder's Obligations. In connection with the Registration Statement
referred above, the Holders shall each:

            (a) Complete, execute, acknowledge and/or deliver such
questionnaires, indemnification agreements, custody agreements, underwriting
agreements (if the registration is underwritten) and other documents,
certificates and instruments as are reasonably required by the Company or any
underwriters(s) or are otherwise necessary in connection with the registration
and offering. Each Holder shall promptly provide to the Company such information
concerning such Holder, its ownership of the Company's securities, the intended
method of distribution and such other information as may be required by
application law or regulation as may be reasonably requested by the Company.

            (b) Upon receipt of any notice from the Company (i) of the happening
of any event of the kind described in Section 2.6(f) or (ii) that the Company no
longer qualifies to use Form S-3, immediately discontinue disposition of the
Registrable Securities pursuant to the Registration Statements covering such
shares until the Holders' receipt of the copies of the supplemented or amended
prospectus contemplated by Section 2.6(f) or until such time the

                                       7
<PAGE>

Company can make an appropriate filing with the SEC or take such further action
so as to qualify the Company to use of Form S-3, and if so directed by the
Company, deliver to the Company all copies of the prospectus covering such
Registrable Securities in such Holder's possession at the time of receipt of
such notice.

            (c) No Holder and no person or entity acting on any Holder's behalf
(other than underwriter selected by the Company or approved by the Company)
shall offer any Registrable Securities by means of any preliminary prospectus.

      2.8 Other Transactions . The Company shall not be obligated to effect a
registration pursuant to Section 2.2, or to file any amendment or supplement
thereto, and may suspend the Holders' rights to make sales pursuant to an
effective registration pursuant to Section 2.2, at any time when the Company, in
the good faith judgment of its Board of Directors, reasonably believes that the
filing thereof at the time requested, or the offering of securities pursuant
thereto, would (i) materially and adversely affect a pending or proposed
acquisition, merger, recapitalization, consolidation, reorganization or similar
transaction, or negotiations, discussions or pending proposals related thereto,
or (ii) be seriously detrimental to the Company and its stockholders, in which
event (under clause (i) or (ii) above) the Company's sole relief from its
registration obligations is the right to defer filing of a registration
statement (or to suspend the Holders' rights to make sales pursuant to an
effective registration pursuant to Section 2.2) for a period of not more than 60
days; provided, however, that the Company shall not utilize the right described
in this Section 2.8 more than twice in any 12-month period.

      2.9 Indemnification. In the event any Registrable Securities are included
in a registration statement under this Agreement:

            (a) To the extent permitted by law, the Company will indemnify and
hold harmless each Holder, the partners, officers and directors of each Holder,
any underwriter (as defined in the Securities Act) for such Holder and each
person, if any, who controls such Holder or underwriter within the meaning of
the Securities Act or the Exchange Act, against any losses, claims, damages, or
liabilities (joint or several) to which they may become subject under the
Securities Act, the Exchange Act or other federal or state law, insofar as such
losses, claims, damages or liabilities (or actions in respect thereof) arise out
of or are based upon any of the following statements, omissions or violations
(collectively a "Violation") by the Company: (i) any untrue statement or alleged
untrue statement of a material fact contained in such registration statement,
including any preliminary prospectus or final prospectus contained therein or
any amendments or supplements thereto, (ii) the omission or alleged omission to
state therein a material fact required to be stated therein, or necessary to
make the statements therein not misleading, or (iii) any violation or alleged
violation by the Company of the Securities Act, the Exchange Act, any state
securities law or any rule or regulation promulgated under the Securities Act,
the Exchange Act or any state securities law in connection with the offering
covered by such registration statement; and the Company will pay as incurred to
each such Holder, partner, officer, director, underwriter or controlling person
for any legal or other expenses reasonably incurred by them in connection with
investigating or defending any such loss, claim, damage, liability or action;
provided however, that the indemnity agreement contained in this Section

                                       8
<PAGE>

2.9(a) shall not apply to amounts paid in settlement of any such loss, claim,
damage, liability or action if such settlement is effected without the consent
of the Company, which consent shall not be unreasonably withheld, nor shall the
Company be liable in any such case for any such loss, claim, damage, liability
or action to the extent that it arises out of or is based upon a Violation which
occurs in reliance upon and in conformity with written information furnished
expressly for use in connection with such registration by such Holder, partner,
officer, director, underwriter or controlling person of such Holder; provided
further, however, that the foregoing indemnity agreement with respect to any
preliminary prospectus shall not inure to the benefit of any Holder or
underwriter, or any person controlling such Holder or underwriter, from whom the
person asserting any such losses, claims, damages or liabilities purchased
shares in the offering, if a copy of the prospectus (as then amended or
supplemented if the Company shall have furnished any amendments or supplements
thereto) was not sent or given by or on behalf of such Holder or underwriter to
such person, if required by law so to have been delivered by such Holder or
underwriter, at or prior to the written confirmation of the sale of the shares
to such person, and if the prospectus (as so amended or supplemented) would have
cured the defect giving rise to such loss, claim, damage or liability.

            (b) To the extent permitted by law, each Holder will, if Registrable
Securities held by such Holder are included in the securities as to which such
registration qualifications or compliance is being effected, indemnify and hold
harmless the Company, each of its directors, its officers and each person, if
any, who controls the Company within the meaning of the Securities Act, any
underwriter and any other Holder selling securities under such registration
statement or any of such other Holder's partners, directors or officers or any
person who controls such Holder, against any losses, claims, damages or
liabilities (joint or several) to which the Company or any such director,
officer, controlling person, underwriter or other such Holder, or partner,
director, officer or controlling person of such other Holder may become subject
under the Securities Act, the Exchange Act or other federal or state law,
insofar as such losses, claims, damages or liabilities (or actions in respect
thereto) arise out of or are based upon any Violation, in each case to the
extent (and only to the extent) that such Violation occurs in reliance upon and
in conformity with written information furnished by such Holder under an
instrument duly executed by such Holder and stated to be specifically for use in
connection with such registration; and each such Holder will pay as incurred any
legal or other expenses reasonably incurred by the Company or any such director,
officer, controlling person, underwriter or other Holder, or partner, officer,
director or controlling person of such other Holder in connection with
investigating or defending any such loss, claim, damage, liability or action if
it is judicially determined that there was such a Violation; provided, however,
that the indemnity agreement contained in this Section 2.9(b) shall not apply to
amounts paid in settlement of any such loss, claim, damage, liability or action
if such settlement is effected without the consent of the Holder, which consent
shall not be unreasonably withheld; provided further, that in no event shall any
indemnity under this Section 2.9 exceed the net proceeds from the offering
received by such Holder.

            (c) Promptly after receipt by an indemnified party under this
Section 2.9 of notice of the commencement of any action (including any
governmental action), such indemnified party

                                       9
<PAGE>

will, if a claim in respect thereof is to be made against any indemnifying party
under this Section 2.9, deliver to the indemnifying party a written notice of
the commencement thereof and the indemnifying party shall have the right to
participate in, and, to the extent the indemnifying party so desires, jointly
with any other indemnifying party similarly noticed, to assume the defense
thereof with counsel mutually satisfactory to the parties; provided, however,
that an indemnified party shall have the right to retain its own counsel, with
the fees and expenses to be paid by the indemnifying party, if representation of
such indemnified party by the counsel retained by the indemnifying party would
be inappropriate due to actual or potential differing interests between such
indemnified party and any other party represented by such counsel in such
proceeding. The failure to deliver written notice to the indemnifying party
within a reasonable time of the commencement of any such action, if materially
prejudicial to its ability to defend such action, shall relieve such
indemnifying party of any liability to the indemnified party under this Section
2.9, but the omission so to deliver written notice to the indemnifying party
will not relieve it of any liability that it may have to any indemnified party
otherwise than under this Section 2.9.

            (d) If the indemnification provided for in this Section 2.9 is held
by a court of competent jurisdiction to be unavailable to an indemnified party
with respect to any losses, claims, damages or liabilities referred to herein,
the indemnifying party, in lieu of indemnifying such indemnified party
thereunder, shall to the extent permitted by applicable law contribute to the
amount paid or payable by such indemnified party as a result of such loss,
claim, damage or liability in such proportion as is appropriate to reflect the
relative fault of the indemnifying party on the one hand and of the indemnified
party on the other in connection with the Violation(s) that resulted in such
loss, claim, damage or liability, as well as any other relevant equitable
considerations. The relative fault of the indemnifying party and of the
indemnified party shall be determined by a court of law by reference to, among
other things, whether the untrue or alleged untrue statement of a material fact
or the omission to state a material fact relates to information supplied by the
indemnifying party or by the indemnified party and the parties' relative intent,
knowledge, access to information and opportunity to correct or prevent such
statement or omission; provided, that in no event shall any contribution by a
Holder hereunder exceed the net proceeds from the offering received by such
Holder.

            (e) The obligations of the Company and Holders under this Section
2.9 shall survive completion of any offering of Registrable Securities in a
registration statement and the termination of this agreement. No Indemnifying
Party, in the defense of any such claim or litigation, shall, except with the
consent of each Indemnified Party, consent to entry of any judgment or enter
into any settlement which does not include as an unconditional term thereof the
giving by the claimant or plaintiff to such Indemnified Party of a release from
all liability in respect to such claim or litigation.

      2.10 Furnishing Information. It shall me a condition precedent to the
obligations of the Company to take any action pursuant to Sections 2.2 and 2.3
that the selling Holder shall furnish to the Company such information regarding
themselves, the Registrable Securities held by them and the intended method of
disposition of such securities as shall be required to effect the registration
of their Registrable Securities.

                                       10
<PAGE>

      2.11 Assignment of Registration Rights. The rights to cause the Company to
register Registrable Securities pursuant to this Section 2 may be assigned by a
Holder to a transferee or assignee of Registrable Securities which (a) is a
subsidiary, parent, general partner, limited partner, retired partner, member or
retired member of a Holder, (b) is a Holder's family member or trust for the
benefit of an individual Holder, or (c) acquires at least 100,000 shares of
Registrable Securities (as adjusted for stock splits and combinations);
provided, however, (i) the transferor shall, within 10 days after such transfer,
furnish to the Company written notice of the name and address of such transferee
or assignee and the securities with respect to which such registration rights
are being assigned and (ii) such transferee shall agree to be subject to all
restrictions set forth in this Agreement.

      2.12 Amendment of Registration Rights. Any provision of this Section 2 may
be amended and the observance thereof may be waived (either generally or in a
particular instance and either retroactively or prospectively), only with the
written consent of the Company and the Holders of at least a majority of the
Registrable Securities then outstanding. Any amendment or waiver effected in
accordance with this Section 2.12 shall be binding upon each Holder and the
Company. By acceptance of any benefits under this Section 2, Holders of
Registrable Securities hereby agree to be bound by the provisions hereunder.

      2.13 Rule 144 Reporting. With a view to making available to the Holders
the benefits of certain rules and regulations of the SEC which may permit the
sale of the Registrable Securities to the public without registration, the
Company agrees to use its best efforts to:

            (a) Make and keep public information available, as those terms are
understood and defined in SEC Rule 144 or any similar or analogous rule
promulgated under the Securities Act, at all times after the effective date of
the first registration filed by the Company for an offering of its securities to
the general public;

            (b) File with the SEC, in a timely manner, all reports and other
documents required of the Company under the Exchange Act; and

            (c) So long as a Holder owns any Registrable Securities, furnish to
such Holder forthwith upon request: a written statement by the Company as to its
compliance with the reporting requirements of said Rule 144 of the Securities
Act, and of the Exchange Act (at any time after it has become subject to such
reporting requirements); a copy of the most recent annual or quarterly report of
the Company; and such other reports and documents as a Holder may reasonably
request in availing itself of any rule or regulation of the SEC allowing it to
sell any such securities without registration.

SECTION 3. COVENANTS OF THE COMPANY.

      3.1 Basic Financial Information and Reporting. The Company will maintain
true books and records of account in which full and correct entries will be made
of all its business transactions pursuant to a system of accounting established
and administered in accordance with

                                       11
<PAGE>

generally accepted accounting principles consistently applied, and will set
aside on its books all such proper accruals and reserves as shall be required
under generally accepted accounting principles consistently applied;

      3.2 Confidentiality of Records. Each Investor agrees to use, and to use
its best efforts to insure that its authorized representatives use, the same
degree of care as such Investor uses to protect its own confidential information
to keep confidential any information furnished to it which the Company
identifies as being confidential or proprietary (so long as such information is
not in the public domain), except that such Investor may disclose such
proprietary or confidential information to any partner, subsidiary or parent of
such Investor for the purpose of evaluating its investment in the Company as
long as such partner, subsidiary or parent is advised of the confidentiality
provisions of this Section 3.2.

      3.3 Reservation of Common Stock. The Company will at all times reserve and
keep available, solely for issuance and delivery upon the conversion of the
Series A Stock, all Common Stock issuable from time to time upon such
conversion.

      3.4 Observer Rights. For so long as MedCapital continues to hold at least
50% of their shares of Series A Stock purchased pursuant to the Purchase
Agreement, the Company shall allow one representative designated by MedCapital
to attend all meetings of the Company's Board of Directors in a nonvoting
capacity, and in connection therewith, the Company shall give such
representative copies of all notices, minutes, consents and other materials,
financial or otherwise, which the Company provides to its Board of Directors;
provided, however, that the Company reserves the right to exclude such
representative from access to any material or meeting or portion thereof if the
Company believes upon advice of counsel that such exclusion is reasonably
necessary to preserve the attorney-client privilege, to protect highly
confidential proprietary information or for other similar reasons. The Company
shall reimburse reasonable expenses of the designated representative for costs
incurred in attending meetings of the Board of Directors on the same basis as
the Company reimburses other directors of the Company.

      3.5 Directors' Expenses. The Company shall reimburse expenses of the
director designated by the holders of the Series A Stock and observer designated
by MedCapital for reasonable costs incurred in attending meetings of the Board
of Directors on the same basis as the Company reimburses other directors of the
Company.

      3.6 Directors' Liability and Indemnification. The Company's Certificate of
Incorporation and Bylaws shall provide (a) for elimination of the liability of
director to the maximum extent permitted by law and (b) for indemnification of
directors for acts on behalf of the Company to the maximum extent permitted by
law. For so long as the holders of Series A Stock, voting separately as a class
in accordance with the Certificate of Designations (as defined in the Purchase
Agreement) shall be entitled to elect one member of the Company's Board of
Directors, the Company shall maintain the Company's existing directors and
officers liability insurance policy (or a substantially equivalent policy) with
coverage up to $10,000,000, provided, however, that should the Board of
Directors in its reasonable discretion determine that the cost to the Company to
maintain such directors and officers liability insurance policy with

                                       12
<PAGE>

coverage up to $10,000,000 has increased materially or the Company cannot obtain
a policy with such limits, the Company shall obtain as much comparable insurance
as shall be available at a cost (no less than the cost of the Company's policy
on the date hereof) which the Company may reasonably afford pursuant to a policy
which shall have been reasonably approved by the Directors, provided further,
however, that in no case shall the coverage for any directors and officers
liability policy be less than $5,000,000.

      3.7 Special Stockholders Meeting. The Company will use its reasonable best
efforts to hold a Special Meeting of Stockholders (the "Special Meeting") within
120 days after the initial Closing Date (as defined in the Purchase Agreement)
under the Purchase Agreement. At the Special Meeting, the stockholders of the
Company will be asked to consider and approve (i) an increase in the number of
shares of Common Stock which the Company is authorized to issue to at least
30,000,000, (ii) an increase in the number of shares of preferred stock which
the Company is authorized to issue to at least 5,000,000 and (iii) an increase
in the number of shares of Common Stock reserved for issuance under the
Company's Plan (as defined in the Purchase Agreement) (or the adoption of a new
stock option plan, as determined by the Board of Directors), to such amount as
the Board of Directors in its reasonable discretion believes appropriate to meet
the incentive compensation needs of the Company for the reasonably foreseeable
future. In addition, at the Special Meeting the Company will seek stockholder
approval to change the fiscal year of the Company to a calendar year unless the
Board reasonably determines, upon the advice of counsel and the Company's
independent auditors, that such change in fiscal year will cause undue expense
to the Company or will otherwise adversely affect the Company in any material
respect.

      3.8 Termination of Covenants. All covenants of the Company contained in
Section 3 of this Agreement shall expire and terminate as to each Investor upon
(i) the sale, lease or other disposition of all or substantially all of the
assets of the Company or (ii) an acquisition of the Company by another
corporation or entity by consolidation, merger or other reorganization in which
the holders of the Company's outstanding voting stock immediately prior to such
transaction own, immediately after such transaction, securities representing
less than 50% of the voting power of the corporation or other entity surviving
such transaction, provided that this Section 3.8(ii) shall not apply to a merger
effected exclusively for the purpose of changing the domicile of the Company.

SECTION 4. MISCELLANEOUS.

      4.1 Governing Law. This Agreement shall be governed by and construed under
the laws of the State of Delaware (without giving effect to principles of
conflict of laws).

      4.2 Survival. The representations, warranties, covenants, and agreements
made herein shall survive any investigation made by any Holder and the closing
of the transactions contemplated hereby. All statements as to factual matters
contained in any certificate or other instrument delivered by or on behalf of
the Company pursuant hereto in connection with the transactions contemplated
hereby shall be deemed to be representations and warranties by the Company
hereunder solely as of the date of such certificate or instrument.

                                       13
<PAGE>

      4.3 Holder Information. Each Holder covenants that it will promptly notify
the Company in writing of any changes in the information set forth in the
Registration Statement regarding such Holder or such Holder's "Plan of
Distribution."

      4.4 Successors and Assigns. Except as otherwise expressly provided herein,
the provisions hereof shall inure to the benefit of, and be binding upon, the
successors, assigns, heirs, executors, and administrators of the parties hereto
and shall inure to the benefit of and be enforceable by each person who shall be
a holder of Registrable Securities from time to time; provided, however, that
prior to the receipt by the Company of adequate written notice of the transfer
of any Registrable Securities specifying the full name and address of the
transferee, the Company may deem and treat the person listed as the holder of
such shares in its records as the absolute owner and holder of such shares for
all purposes, including the payment of dividends or any redemption price.

      4.5 Entire Agreement. This Agreement, the Exhibits, Appendices and
Schedules hereto, the Purchase Agreement and the other documents delivered
pursuant thereto constitute the full and entire understanding and agreement
between the parties with regard to the subjects hereof and no party shall be
liable or bound to any other in any manner by any representations, warranties,
covenants and agreements except as specifically set forth herein and therein.

      4.6 Severability. In the event one or more of the provisions of this
Agreement should, for any reason, be held to be invalid, illegal or
unenforceable in any respect, such invalidity, illegality, or unenforceability
shall not affect any other provisions of this Agreement, and this Agreement
shall be construed as if such invalid, illegal or unenforceable provision had
never been contained herein.

      4.7 Amendment and Waiver.

            (a) Except as otherwise expressly provided, this Agreement may be
amended or modified only upon the written consent of the Company and the holders
of at least a majority of the Registrable Securities.

            (b) Except as otherwise expressly provided, the obligations of the
Company and the rights of the Holders under this Agreement may be waived only
with the written consent of the holders of at least a majority of the
Registrable Securities.

            (c) Notwithstanding the foregoing, this Agreement may be amended
with only the written consent of the Company to include additional purchasers of
Series A Stock as "Investors," "Holders" and parties hereto.

            (d) For the purposes of determining the number of Holder or
Investors entitled to vote or exercise any rights hereunder, the Company shall
be entitled to rely solely on the list of record holders of its stock as
maintained by or on behalf of the Company.

                                       14
<PAGE>

      4.8 Delays or Omissions. It is agreed that no delay or omission to
exercise any right, power, or remedy accruing to any Holder, upon any breach,
default or noncompliance of the Company under this Agreement shall impair any
such right, power, or remedy, nor shall it be construed to be a waiver of any
such breach, default or noncompliance, or any acquiescence therein, or of any
similar breach, default or noncompliance thereafter occurring. It is further
agreed that any waiver, permit, consent, or approval of any kind or character on
any Holder's part of any breach, default or noncompliance under the Agreement or
any waiver on such Holder's part of any provisions or conditions of this
Agreement must be in writing and shall be effective only to the extent
specifically set forth in such writing. All remedies, either under this
Agreement, by law, or otherwise afforded to Holders, shall be cumulative and not
alternative.

      4.9 Notices. All notices required or permitted hereunder shall be in
writing and shall be deemed effectively given: (a) upon personal delivery to the
party to be notified, (b) when sent by confirmed electronic mail or facsimile if
sent during normal business hours of the recipient; if not, then on the next
business day, (c) five days after having been sent by registered or certified
mail, return receipt requested, postage prepaid, or (d) one day after deposit
with a nationally recognized overnight courier, specifying next day delivery,
with written verification of receipt. All communications shall be sent to the
party to be notified at the address as set forth on the signature pages hereof
or Exhibit A hereto or at such other address as such party may designate by 10
days advance written notice to the other parties hereto.

      4.10 Attorneys' Fees. In the event that any suit or action is instituted
to enforce any provision in this Agreement, the prevailing party in such dispute
shall be entitled to recover from the losing party all fees, costs and expenses
of enforcing any right of such prevailing party under or with respect to this
Agreement, including without limitation, such reasonable fees and expenses of
attorneys and accountants, which shall include, without limitation, all fees,
costs and expenses of appeals.

      4.11 Titles and Subtitles. The titles of the sections and subsections of
this Agreement are for convenience of reference only and are not to be
considered in construing this Agreement.

      4.12 Additional Investors. Notwithstanding anything to the contrary
contained herein, if the Company shall issue additional shares of its Series A
Stock pursuant to the Purchase Agreement, any purchaser of such shares of Series
A Stock may become a party to this Agreement by executing and delivering an
additional counterpart signature page to this Agreement and shall be deemed an
"Investor" hereunder.

      4.13 Counterparts. This Agreement may be executed in any number of
counterparts, each of which shall be an original, but all of which together
shall constitute one instrument.

                                       15
<PAGE>

                  [Remainder of Page Intentionally Left Blank]

<PAGE>

      IN WITNESS WHEREOF, the parties hereto have executed this REGISTRATION
RIGHTS AGREEMENT as of the date set forth in the first paragraph hereof.

<TABLE>
<S>                                      <C>
COMPANY:                                 PURCHASERS:

BEI MEDICAL SYSTEMS COMPANY, INC.        RADIUS VENTURE PARTNERS I, L.P.

Signature: /s/ Richard Turner            By: /s/ Jordan Davis      /s/ Daniel Lubin
          ---------------------------       ---------------------------------------
Name: Richard Turner                     Name: Jordan Davis           Daniel Lubin
Title:  President and Chief Executive    Its:  Managing Partner     Managaing Partner
        Officer
100 Hollister Road
Teterboro, New Jersey 07608

                                         MEDCAPITAL, LLC

                                         By: /s/ Jan Rock
                                            ------------------------------------
                                         Name: Jan Rock
                                              ----------------------------------
                                         Its:  Administrative Member
                                              ----------------------------------

                                         FIRST CHICAGO EQUITY CORPORATION

                                         By: /s/ illegible signature
                                            ------------------------------------
                                         Name:
                                              ----------------------------------
                                         Its:
                                             -----------------------------------

                                         CROSS CREEK PARTNERS XI, LLC

                                         By: /s/ illegible signature
                                            ------------------------------------
                                         Name:
                                              ----------------------------------
                                         Its:
                                             -----------------------------------

                                         GARRETT CAPITAL ADVISORS, LLC

                                         By: /s/ Scott Garrett
                                            ------------------------------------
                                         Name: S. Garrett
                                              ----------------------------------
                                         Its:  CEO
                                             -----------------------------------

                                         By:  /s/ Robert P. Khederian
                                            ------------------------------------
                                         Name: ROBERT P. KHEDERIAN
</TABLE>

                         REGISTRATION RIGHTS AGREEMENT
                                 SIGNATURE PAGE
<PAGE>

                                         ROBERT P. KHEDERIAN C/F ROBERT P.
                                         KHEDERIAN, JR. UTMA/MA

                                         By:  /s/ Robert P. Khederian
                                            ------------------------------------
                                         Name: Robert P. Khederian
                                              ----------------------------------
                                         Its:  Custodian
                                              ----------------------------------

                                         ROBERT P. KHEDERIAN C/F ALLISON L.
                                         KHEDERIAN UTMA/MA

                                         By:  /s/ Robert P. Khederian
                                            ------------------------------------
                                         Name: Robert P. Khederian
                                              ----------------------------------
                                         Its:  Custodian
                                              ----------------------------------

                                         DELTA OPPORTUNITY FUND, LTD.
                                         C/O DIAZ & ALTSCHUL ADVISORS, LLC

                                         By: /s/ Christopher S. Mooney
                                            ------------------------------------
                                         Name:  Christopher S. Mooney
                                              ----------------------------------
                                         Its: CFO
                                              ----------------------------------

                                         DELTA OPPORTUNITY FUND (INSTITUTIONAL),
                                         LLC  C/O DIAZ & ALTSCHUL ADVISORS, LLC

                                         By: /s/ Christopher S. Mooney
                                            ------------------------------------
                                         Name:  Christopher S. Mooney
                                              ----------------------------------
                                         Its: CFO
                                              ----------------------------------

                                         OVERBROOK FUND I, LLC

                                         By:  /s/ A. G. Altschid. Jr.
                                            ------------------------------------
                                         Name:  Arthru G. Altshid, Jr.
                                              ----------------------------------
                                         Its:  Managing Member
                                              ----------------------------------

                                         OSCAR SCHAFER

                                         /s/ Oscar Schafer
                                         ---------------------------------------
                                         Name: OSCAR SCHAFER
<PAGE>

                         REGISTRATION RIGHTS AGREEMENT

                                    EXHIBIT A

                              SCHEDULE OF investors

NAME AND ADDRESS                                             SHARES

RADIUS VENTURE PARTNERS I, L.P.                             266,667
One Rockefeller Plaza
Suite 920
New York, NY 10020
Attn:  Jordan S. Davis

MEDCAPITAL, LLC                                             133,333
500 CAMPUS DRIVE
SUITE 220
FLORHAM PARK, NJ 07932

FIRST CHICAGO EQUITY CORPORATION                            252,067
55 WEST MONROE
16TH FLOOR
CHICAGO, IL 60670-0610

CROSS CREEK PARTNERS XI, LLC                                1,267
55 WEST MONROE
16TH FLOOR
CHICAGO, IL 60670-0610

GARRETT CAPITAL ADVISORS, LLC                               13,334
55 WEST MONROE
16TH FLOOR
CHICAGO, IL 60670-0610

ROBERT P. KHEDERIAN                                         78,161
200 POND ROAD
WELLESLEY, MA 02482

ROBERT P. KHEDERIAN C/F ROBERT P.                           78,161
KHEDERIAN, JR. UTMA/MA
200 POND ROAD
WELLESLEY, MA 02482
ROBERT P. KHEDERIAN C/F ALLISON L.                          78,161
KHEDERIAN UTMA/MA
200 POND ROAD
WELLESLEY, MA 02482

                                      A-1
<PAGE>

DELTA OPPORTUNITY FUND, LTD.                                80,000
C/O DIAZ & ALTSCHUL ADVISORS, LLC
ATTN: REINALDO M. DIAZ
950 THIRD AVENUE, 16TH FLOOR
NEW YORK, NY 10022

DELTA OPPORTUNITY FUND                                      53,334
(INSTITUTIONAL), LLC
C/O DIAZ & ALTSCHUL ADVISORS, LLC
ATTN: REINALDO M. DIAZ
950 THIRD AVENUE, 16TH FLOOR
NEW YORK, NY 10022

OSCAR S. SCHAFER                                            13,333
150 CENTRAL PARK SOUTH
APARTMENT 3601
NEW YORK, NEW YORK 10019

OVERBROOK FUND I, LLC                                       66,667
C/O OVERBROOK MANAGEMENT
ATTN: NORA JOBSON
521 5TH AVENUE, SUITE 1501
NEW YORK, NY  10175

                                                         ---------
TOTAL:                                                   1,114,485
                                                         =========

                                       A-2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00021-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00021-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00021-of-00352.parquet"}]]